306 related articles for article (PubMed ID: 28013204)
1. Modelling clinical systemic lupus erythematosus: similarities, differences and success stories.
Celhar T; Fairhurst AM
Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i88-i99. PubMed ID: 28013204
[TBL] [Abstract][Full Text] [Related]
2. Genetics of systemic autoimmunity in mouse models of lupus.
Kono DH; Theofilopoulos AN
Int Rev Immunol; 2000; 19(4-5):367-87. PubMed ID: 11016424
[TBL] [Abstract][Full Text] [Related]
3. Murine models of systemic lupus erythematosus.
Perry D; Sang A; Yin Y; Zheng YY; Morel L
J Biomed Biotechnol; 2011; 2011():271694. PubMed ID: 21403825
[TBL] [Abstract][Full Text] [Related]
4. Genome screening for susceptibility loci in systemic lupus erythematosus.
Shirai T; Nishimura H; Jiang Y; Hirose S
Am J Pharmacogenomics; 2002; 2(1):1-12. PubMed ID: 12083950
[TBL] [Abstract][Full Text] [Related]
5. Genetic basis of murine lupus.
Santiago-Raber ML; Laporte C; Reininger L; Izui S
Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
[TBL] [Abstract][Full Text] [Related]
6. Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus.
Crampton SP; Morawski PA; Bolland S
Dis Model Mech; 2014 Sep; 7(9):1033-46. PubMed ID: 25147296
[TBL] [Abstract][Full Text] [Related]
7. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
9. Regulatory B cells in mouse models of systemic lupus erythematosus (SLE).
Matsushita T
Methods Mol Biol; 2014; 1190():195-205. PubMed ID: 25015282
[TBL] [Abstract][Full Text] [Related]
10. Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models.
Cheung YH; Loh C; Pau E; Kim J; Wither J
Semin Immunol; 2009 Dec; 21(6):372-82. PubMed ID: 19926489
[TBL] [Abstract][Full Text] [Related]
11. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
Meryhew NL; Shaver C; Messner RP; Runquist OA
J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility genes in the pathogenesis of murine lupus.
Nguyen C; Limaye N; Wakeland EK
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S255-63. PubMed ID: 12110145
[TBL] [Abstract][Full Text] [Related]
13. Relevance of systemic lupus erythematosus nephritis animal models to human disease.
Foster MH
Semin Nephrol; 1999 Jan; 19(1):12-24. PubMed ID: 9952277
[TBL] [Abstract][Full Text] [Related]
14. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
15. An update on diet and nutritional factors in systemic lupus erythematosus management.
Aparicio-Soto M; Sánchez-Hidalgo M; Alarcón-de-la-Lastra C
Nutr Res Rev; 2017 Jun; 30(1):118-137. PubMed ID: 28294088
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
18. General aspects of the genetics of SLE.
Rhodes B; Vyse TJ
Autoimmunity; 2007 Dec; 40(8):550-9. PubMed ID: 18075789
[TBL] [Abstract][Full Text] [Related]
19. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
20. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
